{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T12:07:46Z","timestamp":1786622866216,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13011-016-0056-3","type":"journal-article","created":{"date-parts":[[2016,3,5]],"date-time":"2016-03-05T12:56:45Z","timestamp":1457182605000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Recruitment to doping and help-seeking behavior of eight female AAS users"],"prefix":"10.1186","volume":"11","author":[{"given":"Annica","family":"B\u00f6rjesson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"G\u00e5revik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja-Liisa","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Rane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Ekstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,5]]},"reference":[{"key":"56_CR1","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/j.1360-0443.2009.02734.x","volume":"104","author":"G Kanayama","year":"2009","unstructured":"Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope Jr HG. Anabolic-androgenic steroid dependence: an emerging disorder. Addiction. 2009;104:1966\u201378.","journal-title":"Addiction"},{"key":"56_CR2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00228-003-0633-z","volume":"59","author":"AC Eklof","year":"2003","unstructured":"Eklof AC, Thurelius AM, Garle M, Rane A, Sjoqvist F. The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology. Eur J Clin Pharmacol. 2003;59:571\u20137.","journal-title":"Eur J Clin Pharmacol"},{"key":"56_CR3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.annepidem.2014.01.009","volume":"24","author":"D Sagoe","year":"2014","unstructured":"Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol. 2014;24:383\u201398.","journal-title":"Ann Epidemiol"},{"key":"56_CR4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugalcdep.2006.10.013","volume":"88","author":"G Kanayama","year":"2007","unstructured":"Kanayama G, Boynes M, Hudson JI, Field AE, Pope Jr HG. Anabolic steroid abuse among teenage girls: an illusory problem? Drug Alcohol Depend. 2007;88:156\u201362.","journal-title":"Drug Alcohol Depend"},{"key":"56_CR5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/JSM.0b013e3181fb5370","volume":"20","author":"EJ Ip","year":"2010","unstructured":"Ip EJ, Barnett MJ, Tenerowicz MJ, Kim JA, Wei H, Perry PJ. Women and anabolic steroids: an analysis of a dozen users. Clin J Sport Med. 2010;20:475\u201381.","journal-title":"Clin J Sport Med"},{"key":"56_CR6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/archpedi.1997.02170490023005","volume":"151","author":"CE Yesalis","year":"1997","unstructured":"Yesalis CE, Barsukiewicz CK, Kopstein AN, Bahrke MS. Trends in anabolic-androgenic steroid use among adolescents. Arch Pediatr Adolesc Med. 1997;151:1197\u2013206.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"56_CR7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000012362","volume":"69","author":"AJ Gruber","year":"2000","unstructured":"Gruber AJ, Pope Jr HG. Psychiatric and medical effects of anabolic-androgenic steroid use in women. Psychother Psychosom. 2000;69:19\u201326.","journal-title":"Psychother Psychosom"},{"key":"56_CR8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.drugpo.2014.10.004","volume":"26","author":"D Sagoe","year":"2015","unstructured":"Sagoe D, Torsheim T, Molde H, Andreassen CS, Pallesen S. Attitudes towards use of anabolic-androgenic steroids among Ghanaian high school students. Int J Drug Policy. 2015;26:169\u201374.","journal-title":"Int J Drug Policy"},{"key":"56_CR9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/bjsm.2009.068924","volume":"44","author":"PA Harmer","year":"2010","unstructured":"Harmer PA. Anabolic-androgenic steroid use among young male and female athletes: is the game to blame? Br J Sports Med. 2010;44:26\u201331.","journal-title":"Br J Sports Med"},{"key":"56_CR10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00042752-200101000-00009","volume":"11","author":"GA Green","year":"2001","unstructured":"Green GA, Uryasz FD, Petr TA, Bray CD. NCAA study of substance use and abuse habits of college student-athletes. Clin J Sport Med. 2001;11:51\u20136.","journal-title":"Clin J Sport Med"},{"key":"56_CR11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jemermed.2009.09.026","volume":"40","author":"EB Lust","year":"2011","unstructured":"Lust EB, Barthold C, Malesker MA, Wichman TO. Human health hazards of veterinary medications: information for emergency departments. J Emerg Med. 2011;40:198\u2013207.","journal-title":"J Emerg Med"},{"key":"56_CR12","first-page":"E50","volume":"263","author":"JJ Choo","year":"1992","unstructured":"Choo JJ, Horan MA, Little RA, Rothwell NJ. Anabolic effects of clenbuterol on skeletal muscle are mediated by beta 2-adrenoceptor activation. Am J Physiol. 1992;263:E50\u201356.","journal-title":"Am J Physiol"},{"key":"56_CR13","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1001\/jama.1985.03350430083032","volume":"253","author":"RH Strauss","year":"1985","unstructured":"Strauss RH, Liggett MT, Lanese RR. Anabolic steroid use and perceived effects in ten weight-trained women athletes. JAMA. 1985;253:2871\u20133.","journal-title":"JAMA"},{"key":"56_CR14","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0002-9378(12)90768-1","volume":"165","author":"WB Malarkey","year":"1991","unstructured":"Malarkey WB, Strauss RH, Leizman DJ, Liggett M, Demers LM. Endocrine effects in female weight lifters who self-administer testosterone and anabolic steroids. Am J Obstet Gynecol. 1991;165:1385\u201390.","journal-title":"Am J Obstet Gynecol"},{"key":"56_CR15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jsbmb.2011.08.005","volume":"127","author":"N Garevik","year":"2011","unstructured":"Garevik N, Strahm E, Garle M, Lundmark J, Stahle L, Ekstrom L, et al. Long term perturbation of endocrine parameters and cholesterol metabolism after discontinued abuse of anabolic androgenic steroids. J Steroid Biochem Mol Biol. 2011;127:295\u2013300.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"56_CR16","doi-asserted-by":"crossref","unstructured":"Mullen JE, G\u00e5revik N, Schulze JJ, Rane A, Bergman LB, Ekstr\u00f6m L. Perturbation of the Hematopoietic Profile by Anabolic Androgenic Steroids. J Hormones. 2014;2014:7 Article ID 510257.","DOI":"10.1155\/2014\/510257"},{"key":"56_CR17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1747-597X-3-24","volume":"3","author":"K Skarberg","year":"2008","unstructured":"Skarberg K, Nyberg F, Engstrom I. The development of multiple drug use among anabolic-androgenic steroid users: six subjective case reports. Subst Abuse Treat Prev Policy. 2008;3:24.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"56_CR18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0010-440X(99)90127-X","volume":"40","author":"AJ Gruber","year":"1999","unstructured":"Gruber AJ, Pope Jr HG. Compulsive weight lifting and anabolic drug abuse among women rape victims. Compr Psychiatry. 1999;40:273\u20137.","journal-title":"Compr Psychiatry"},{"key":"56_CR19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.drugalcdep.2010.04.008","volume":"111","author":"A Petersson","year":"2010","unstructured":"Petersson A, Bengtsson J, Voltaire-Carlsson A, Thiblin I. Substance abusers\u2019 motives for using anabolic androgenic steroids. Drug Alcohol Depend. 2010;111:170\u20132.","journal-title":"Drug Alcohol Depend"},{"key":"56_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/JA-200030485","volume":"40","author":"S Nilsson","year":"2005","unstructured":"Nilsson S, Spak F, Marklund B, Baigi A, Allebeck P. Attitudes and behaviors with regards to androgenic anabolic steroids among male adolescents in a county of Sweden. Subst Use Misuse. 2005;40:1\u201312.","journal-title":"Subst Use Misuse"},{"key":"56_CR21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0022-3956(94)90019-1","volume":"28","author":"KJ Brower","year":"1994","unstructured":"Brower KJ, Blow FC, Hill EM. Risk factors for anabolic-androgenic steroid use in men. J Psychiatr Res. 1994;28:369\u201380.","journal-title":"J Psychiatr Res"},{"key":"56_CR22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.drugalcdep.2009.02.008","volume":"102","author":"G Kanayama","year":"2009","unstructured":"Kanayama G, Hudson JI, Pope Jr HG. Features of men with anabolic-androgenic steroid dependence: a comparison with nondependent AAS users and with AAS nonusers. Drug Alcohol Depend. 2009;102:130\u20137.","journal-title":"Drug Alcohol Depend"},{"key":"56_CR23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0306-4603(98)00060-4","volume":"24","author":"K Lovstakken","year":"1999","unstructured":"Lovstakken K, Peterson L, Homer AL. Risk factors for anabolic steroid use in college students and the role of expectancy. Addict Behav. 1999;24:425\u201330.","journal-title":"Addict Behav"},{"key":"56_CR24","first-page":"625","volume":"51","author":"MW Elmlinger","year":"2005","unstructured":"Elmlinger MW, Kuhnel W, Wormstall H, Doller PC. Reference intervals for testosterone, androstenedione and SHBG levels in healthy females and males from birth until old age. Clin Lab. 2005;51:625\u201332.","journal-title":"Clin Lab"},{"key":"56_CR25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/archpsyc.1994.03950050035004","volume":"51","author":"HG Pope Jr","year":"1994","unstructured":"Pope Jr HG, Katz DL. Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Arch Gen Psychiatry. 1994;51:375\u201382.","journal-title":"Arch Gen Psychiatry"},{"key":"56_CR26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/02652030601013729","volume":"24","author":"S Martello","year":"2007","unstructured":"Martello S, Felli M, Chiarotti M. Survey of nutritional supplements for selected illegal anabolic steroids and ephedrine using LC-MS\/MS and GC-MS methods, respectively. Food Addit Contam. 2007;24:258\u201365.","journal-title":"Food Addit Contam"},{"key":"56_CR27","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/02640410400023258","volume":"23","author":"RJ Maughan","year":"2005","unstructured":"Maughan RJ. Contamination of dietary supplements and positive drug tests in sport. J Sports Sci. 2005;23:883\u20139.","journal-title":"J Sports Sci"},{"key":"56_CR28","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1210\/jc.2004-1526","volume":"90","author":"WM Bagchus","year":"2005","unstructured":"Bagchus WM, Smeets JM, Verheul HA, De Jager-Van Der Veen SM, Port A, Geurts TB. Pharmacokinetic evaluation of three different intramuscular doses of nandrolone decanoate: analysis of serum and urine samples in healthy men. J Clin Endocrinol Metab. 2005;90:2624\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"56_CR29","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1249\/01.mss.0000210194.56834.5d","volume":"38","author":"AB Parkinson","year":"2006","unstructured":"Parkinson AB, Evans NA. Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc. 2006;38:644\u201351.","journal-title":"Med Sci Sports Exerc"},{"key":"56_CR30","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/09595230802392568","volume":"27","author":"B Larance","year":"2008","unstructured":"Larance B, Degenhardt L, Copeland J, Dillon P. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs. Drug Alcohol Rev. 2008;27:679\u201386.","journal-title":"Drug Alcohol Rev"},{"key":"56_CR31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1521-0391.1998.tb00344.x","volume":"7","author":"AJ Gruber","year":"1998","unstructured":"Gruber AJ, Pope Jr HG. Ephedrine abuse among 36 female weightlifters. Am J Addict. 1998;7:256\u201361.","journal-title":"Am J Addict"},{"key":"56_CR32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13011-015-0006-5","volume":"10","author":"D Sagoe","year":"2015","unstructured":"Sagoe D, McVeigh J, Bjornebekk A, Essilfie MS, Andreassen CS, Pallesen S. Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis. Subst Abuse Treat Prev Policy. 2015;10:12.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"56_CR33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.forsciint.2012.01.004","volume":"219","author":"Y Lood","year":"2012","unstructured":"Lood Y, Eklund A, Garle M, Ahlner J. Anabolic androgenic steroids in police cases in Sweden 1999\u20132009. Forensic Sci Int. 2012;219:199\u2013204.","journal-title":"Forensic Sci Int"},{"key":"56_CR34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.drugalcdep.2009.12.024","volume":"109","author":"N Garevik","year":"2010","unstructured":"Garevik N, Rane A. Dual use of anabolic-androgenic steroids and narcotics in Sweden. Drug Alcohol Depend. 2010;109:144\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"56_CR35","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jemermed.2012.02.057","volume":"44","author":"DS Huckins","year":"2013","unstructured":"Huckins DS, Lemons MF. Myocardial ischemia associated with clenbuterol abuse: report of two cases. J Emerg Med. 2013;44:444\u20139.","journal-title":"J Emerg Med"},{"key":"56_CR36","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1253\/circj.69.1144","volume":"69","author":"B Kierzkowska","year":"2005","unstructured":"Kierzkowska B, Stanczyk J, Kasprzak JD. Myocardial infarction in a 17-year-old body builder using clenbuterol. Circ J. 2005;69:1144\u20136.","journal-title":"Circ J"},{"key":"56_CR37","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1249\/00005768-199508000-00003","volume":"27","author":"ID Prather","year":"1995","unstructured":"Prather ID, Brown DE, North P, Wilson JR. Clenbuterol: a substitute for anabolic steroids? Med Sci Sports Exerc. 1995;27:1118\u201321.","journal-title":"Med Sci Sports Exerc"},{"key":"56_CR38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/106002809502900114","volume":"29","author":"C Spann","year":"1995","unstructured":"Spann C, Winter ME. Effect of clenbuterol on athletic performance. Ann Pharmacother. 1995;29:75\u20137.","journal-title":"Ann Pharmacother"},{"key":"56_CR39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/MED.0b013e3283524008","volume":"19","author":"G Kanayama","year":"2012","unstructured":"Kanayama G, Pope Jr HG. Illicit use of androgens and other hormones: recent advances. Curr Opin Endocrinol Diabetes Obes. 2012;19:211\u20139.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"56_CR40","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/978-3-540-79088-4_18","volume":"195","author":"P Vanberg","year":"2010","unstructured":"Vanberg P, Atar D. Androgenic anabolic steroid abuse and the cardiovascular system. Handb Exp Pharmacol. 2010;195:411\u201357.","journal-title":"Handb Exp Pharmacol"},{"key":"56_CR41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2147\/SAR.S71285","volume":"5","author":"N Garevik","year":"2014","unstructured":"Garevik N, Rane A, Bjorkhem-Bergman L, Ekstrom L. Effects of different doses of testosterone on gonadotropins, 25-hydroxyvitamin D3, and blood lipids in healthy men. Subst Abuse Rehabil. 2014;5:121\u20137.","journal-title":"Subst Abuse Rehabil"},{"key":"56_CR42","doi-asserted-by":"crossref","unstructured":"Garevik N, Borjesson A, Choong E, Ekstrom L, Lehtihet M. Impact of single-dose nandrolone decanoate on gonadotropins, blood lipids and HMG CoA reductase in healthy men. Andrologia. 2015 doi: 10.1111\/and.12488","DOI":"10.1111\/and.12488"},{"key":"56_CR43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1747-597X-7-12","volume":"7","author":"N Garevik","year":"2012","unstructured":"Garevik N, Skogastierna C, Rane A, Ekstrom L. Single dose testosterone increases total cholesterol levels and induces the expression of HMG CoA Reductase. Subst Abuse Treat Prev Policy. 2012;7:12.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"56_CR44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3945\/ajcn.115.112227","volume":"102","author":"S Engel","year":"2015","unstructured":"Engel S, Tholstrup T. Butter increased total and LDL cholesterol compared with olive oil but resulted in higher HDL cholesterol compared with a habitual diet. Am J Clin Nutr. 2015;102:309\u201315.","journal-title":"Am J Clin Nutr"},{"key":"56_CR45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1249\/JSR.0000000000000073","volume":"13","author":"B Gordon","year":"2014","unstructured":"Gordon B, Chen S, Durstine JL. The effects of exercise training on the traditional lipid profile and beyond. Curr Sports Med Rep. 2014;13:253\u20139.","journal-title":"Curr Sports Med Rep"},{"key":"56_CR46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MOL.0b013e32835df2d6","volume":"24","author":"FW Asselbergs","year":"2013","unstructured":"Asselbergs FW, Lovering RC, Drenos F. Progress in genetic association studies of plasma lipids. Curr Opin Lipidol. 2013;24:123\u20138.","journal-title":"Curr Opin Lipidol"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-016-0056-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T07:45:00Z","timestamp":1567669500000},"score":1,"resource":{"primary":{"URL":"http:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-016-0056-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,5]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["56"],"URL":"https:\/\/doi.org\/10.1186\/s13011-016-0056-3","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,5]]},"article-number":"11"}}